Postdiagnosis Changes in Cigarette Smoking and Survival Following Breast Cancer

Abstract

Background The purpose of this study was to examine whether at-diagnosis smoking and postdiagnosis changes in smoking within five years after breast cancer were associated with long-term all-cause and breast cancer-specific mortality. Methods A population-based cohort of 1508 women diagnosed with first primary in situ or invasive breast cancer in 1996 to 1997 were interviewed shortly after diagnosis and again approximately five years later to assess smoking history. Participants were followed for vital status through December 31, 2014. After 18+ years of follow-up, 597 deaths were identified, 237 of which were breast cancer related. Multivariable Cox regression was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Results Compared with never smokers, risk of all-cause mortality was elevated among the 19% of at-diagnosis smokers (HR=1.69, 95% CI=1.36 to 2.11), those who smoked 20 or more cigarettes per day (HR=1.85, 95% CI=1.42 to 2.40), women who had smoked for 30 or more years (HR=1.62, 95% CI=1.28 to 2.05), and women who had smoked 30 or more pack-years (HR=1.82, 95% CI=1.39 to 2.37). Risk of all-cause mortality was further increased among the 8% of women who were at-/post-diagnosis smokers (HR=2.30, 95% CI=1.56 to 3.39) but was attenuated among the 11% women who quit smoking after diagnosis (HR=1.83, 95% CI=1.32 to 2.52). Compared with never smokers, breast cancer–specific mortality risk was elevated 60% (HR=1.60, 95% CI=0.79 to 3.23) among at-/postdiagnosis current smokers, but the confidence interval included the null value and elevated 175% (HR=2.75, 95% CI=1.26 to 5.99) when we considered postdiagnosis cumulative pack-years. Conclusions: Smoking negatively impacts long-term survival after breast cancer. Postdiagnosis cessation of smoking may reduce the risk of all-cause mortality. Breast cancer survivors may benefit from aggressive smoking cessation programs starting as early as the time of diagnosis.

Prediagnosis and postdiagnosis smoking and survival following diagnosis with ovarian cancer

“…Tobacco smoke is a highly proinflammatory and toxic substance, which is a cause of premature death from multiple conditions, including cancers . Smoking may enhance the invasive potential of cancer cells, increase the risk of cancer recurrence and development of second primary cancers, alter cancer drug metabolism and promote the development of thrombosis, which are all associated with an increased risk of mortality.…”

Sociodemographic, Clinical, and Pathological Factors Influencing Outcomes in Locally Advanced Triple Negative Breast Cancer: A Brazilian Cohort

“…A meta-analysis published in 2013 pointed out that only a more regular and heavy alcohol intake, greater than 20 g/day, would be consistently associated with increased breast cancer mortality and earlier recurrence. 21 Apparently, there may be some interference of alcohol on pharmacokinetics of chemotherapy as well as social implications that lead to lower adherence to treatment. As for smoking, it could not be confirmed as a predictive factor for NACT or as a prognostic factor.…”

Abordaje de la enfermedad cardiovascular en mujeres con cáncer de mama. Posición de la Asociación Nacional de Cardiólogos de México (ANCAM)

“…Suspension reduces the risk of death in women with BC. 36 Among the main causes of mortality attributable to this habit are MI and cerebrovascular disease. Mortality is proportional to its intensity, being 1.3 (95% CI 1.2-1.4) with 10 cigars/day and 1.8 (95% CI 1.7-1.9) with more than 10.…”

“…40 If the woman smokes at diagnosis increases the risk of death from any cause 69%; if she continues to smoke, the risk increases by 130%. 36 Alcoholism. Alcohol consumption in women cannot be suggested as a CV 41 prevention measure, as epidemiological and meta-analysis (MA) have shown beneficial effects as harmful in relation to consumption level and age.…”